atenolol has been researched along with Cardiovascular Pregnancy Complications in 49 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atenolol use may be associated with growth retardation when given in pregnancy, although the relationship to trimester of initiation, duration of treatment, and its use as monotherapy is still uncertain." | 9.09 | Atenolol and fetal growth in pregnancies complicated by hypertension. ( Beevers, DG; Beevers, M; Lip, GY; Lydakis, C, 1999) |
| "29 women with pregnancy induced hypertension in the third trimester, 13 randomised to atenolol and 16 to pindolol." | 9.07 | Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. ( Ingemarsson, I; Marsál, K; Montan, S; Sjöberg, NO, 1992) |
| "This study assessed the effectiveness of atenolol in the treatment of moderate and severe hypertension during pregnancy." | 9.07 | Effectiveness of atenolol in the treatment of hypertension during pregnancy. ( Alvarez, L; Baglivo, HP; Cerrato, C; Drisaldi, S; Esper, RJ; Fabregues, G; Moschettoni, C; Pituelo, D; Varas Juri, P, 1992) |
| "To determine the effect of atenolol on the outcome of pregnancy in women with essential hypertension." | 9.06 | Atenolol in essential hypertension during pregnancy. ( Butters, L; Kennedy, S; Rubin, PC, 1990) |
| "Atenolol was compared with placebo in a randomised and double-blind prospective study of 120 women with mild to moderate pregnancy-associated hypertension who were also initially managed conventionally by bed rest." | 9.05 | Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. ( Butters, L; Clark, DM; Low, RA; Reid, JL; Reynolds, B; Rubin, PC; Steedman, D; Sumner, DJ, 1983) |
| "The obstetric implications of the use of the beta-adrenoceptor antagonist atenolol have been evaluated in a prospective, randomized, double-blind, and placebo-controlled study involving 120 women with pregnancy-associated hypertension." | 9.05 | Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. ( Belfield, A; Butters, L; Clark, D; Low, RA; Pledger, D; Reid, JL; Rubin, PC; Sumner, D, 1984) |
| "We describe the results of a prospective study in which 120 women who developed hypertension in the last trimester of pregnancy were randomly allocated in double blind manner to atenolol or placebo." | 9.05 | First year of life after the use of atenolol in pregnancy associated hypertension. ( Adams, T; Butters, L; Evans, J; Reynolds, B; Rubin, PC, 1984) |
| "The salivary activity in pups of spontaneously hypertensive rats (SHR) and Wistar (W) rats treated with atenolol during pregnancy, and lactation was evaluated." | 7.74 | Atenolol reduces salivary activity in pups of spontaneously hypertensive and normotensive rats treated during pregnancy and lactation. ( Antoniali, C; Delbem, AC; Elias, GP; Sassaki, KT, 2008) |
| "A retrospective review of patients treated in early pregnancy with atenolol was conducted." | 7.71 | Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. ( Brateng, D; Carr, DB; Diederichs, C; Easterling, TR; Schmucker, B, 2001) |
| "To investigate the possible harmful effects of early antihypertensive drug therapy with atenolol versus other therapies on pregnancy outcome, we reviewed the records of 398 women referred to our antenatal hypertension clinic between 1980 and 1995." | 7.69 | Effect of atenolol on birth weight. ( Beevers, DG; Beevers, M; Churchill, D; Lip, GY; Shaffer, LM, 1997) |
| "Adenosine is effective in rapidly terminating maternal narrow complex tachyarrhythmias before and during delivery in women with Wolff-Parkinson-White syndrome." | 7.68 | Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome. ( Afridi, I; Moise, KJ; Rokey, R, 1992) |
| "Fetal circulation was studied by means of combined real-time and pulsed Doppler ultrasound in 14 women with pregnancy-associated hypertension before and during the first and third days of treatment with the beta 1-selective blocker, atenolol; in seven of the women the maternal uterine arcuate blood velocity waveform was also studied." | 7.67 | Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy. ( Liedholm, H; Lingman, G; Marsál, K; Montan, S; Sjöberg, NO; Solum, T, 1987) |
| "Slow-release nifedipine has been used in the treatment of severe hypertension in 23 pregnant women." | 7.67 | Nifedipine as a second line antihypertensive drug in pregnancy. ( Beevers, DG; Constantine, G; Luesley, DM; Reynolds, AL, 1987) |
| "This study reports the results that were obtained in 56 cases of arterial hypertension in pregnancy solely by beta-blocking with Atenolol or Labetalol." | 7.66 | [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol]. ( Beauséjour, B; Blazquez, G; Faurie, C; Flouvat, B; Gérard, J; Lardoux, H; Rousset, D, 1983) |
| "1 The pharmacological properties of atenolol suggest its possible usefulness in pregnancy-induced hypertension." | 7.66 | Atenolol in the treatment of pregnancy-induced hypertension. ( Cruickshank, JM; McAinsh, J; Thorley, KJ, 1981) |
| "Atenolol has been studied prospectively in the management of ten patients with essential hypertension during pregnancy." | 7.66 | Atenolol in the treatment of essential hypertension during pregnancy. ( Butters, L; Low, RA; Reid, JL; Rubin, PC, 1982) |
| " The average daily dosage was 144." | 5.27 | Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol. ( Blazquez, G; Chouty, F; Flouvat, B; Gerard, J; Lardoux, H, 1983) |
| "To study clinical efficiency of atenolol in pregnancy hypertension with consideration of its cardiodynamic effects." | 5.09 | [Atenolol use in gestosis: clinical and hemodynamic aspects]. ( Elokhina, TB; Petrova, SB; Shekhtman, MM; Sokolova, MIu, 2000) |
| "Atenolol use may be associated with growth retardation when given in pregnancy, although the relationship to trimester of initiation, duration of treatment, and its use as monotherapy is still uncertain." | 5.09 | Atenolol and fetal growth in pregnancies complicated by hypertension. ( Beevers, DG; Beevers, M; Lip, GY; Lydakis, C, 1999) |
| "To evaluate the short-term effects of intravenously given atenolol and pindolol on utero- and umbilicoplacental vascular impedance, fetal hemodynamics and cardiac function in patients suffering from pregnancy-induced hypertension." | 5.08 | Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study. ( Jouppila, P; Räsänen, J, 1995) |
| "This study assessed the effectiveness of atenolol in the treatment of moderate and severe hypertension during pregnancy." | 5.07 | Effectiveness of atenolol in the treatment of hypertension during pregnancy. ( Alvarez, L; Baglivo, HP; Cerrato, C; Drisaldi, S; Esper, RJ; Fabregues, G; Moschettoni, C; Pituelo, D; Varas Juri, P, 1992) |
| "29 women with pregnancy induced hypertension in the third trimester, 13 randomised to atenolol and 16 to pindolol." | 5.07 | Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. ( Ingemarsson, I; Marsál, K; Montan, S; Sjöberg, NO, 1992) |
| "To determine the effect of atenolol on the outcome of pregnancy in women with essential hypertension." | 5.06 | Atenolol in essential hypertension during pregnancy. ( Butters, L; Kennedy, S; Rubin, PC, 1990) |
| " The incidence of severe hypertension was significantly lower when nifedipine (odds ratio, 0." | 5.05 | Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. ( Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V, 2020) |
| "Atenolol was compared with placebo in a randomised and double-blind prospective study of 120 women with mild to moderate pregnancy-associated hypertension who were also initially managed conventionally by bed rest." | 5.05 | Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. ( Butters, L; Clark, DM; Low, RA; Reid, JL; Reynolds, B; Rubin, PC; Steedman, D; Sumner, DJ, 1983) |
| "We describe the results of a prospective study in which 120 women who developed hypertension in the last trimester of pregnancy were randomly allocated in double blind manner to atenolol or placebo." | 5.05 | First year of life after the use of atenolol in pregnancy associated hypertension. ( Adams, T; Butters, L; Evans, J; Reynolds, B; Rubin, PC, 1984) |
| "The obstetric implications of the use of the beta-adrenoceptor antagonist atenolol have been evaluated in a prospective, randomized, double-blind, and placebo-controlled study involving 120 women with pregnancy-associated hypertension." | 5.05 | Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. ( Belfield, A; Butters, L; Clark, D; Low, RA; Pledger, D; Reid, JL; Rubin, PC; Sumner, D, 1984) |
| "Our findings suggest that neonates born to mothers exposed to β blockers in late pregnancy, including labetalol, are at elevated risk for neonatal hypoglycemia and bradycardia." | 3.83 | Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. ( Bateman, BT; Desai, RJ; Fischer, MA; Hernandez-Diaz, S; Huybrechts, KF; Maeda, A; Mogun, H; Patorno, E; Seely, EW, 2016) |
| "The salivary activity in pups of spontaneously hypertensive rats (SHR) and Wistar (W) rats treated with atenolol during pregnancy, and lactation was evaluated." | 3.74 | Atenolol reduces salivary activity in pups of spontaneously hypertensive and normotensive rats treated during pregnancy and lactation. ( Antoniali, C; Delbem, AC; Elias, GP; Sassaki, KT, 2008) |
| "A retrospective review of patients treated in early pregnancy with atenolol was conducted." | 3.71 | Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. ( Brateng, D; Carr, DB; Diederichs, C; Easterling, TR; Schmucker, B, 2001) |
| "Atenolol taken at the time of conception and/or during the first trimester of pregnancy was associated with low birth weight." | 3.71 | Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester? ( Bayliss, H; Beevers, DG; Beevers, M; Churchill, D, 2002) |
| "To investigate the possible harmful effects of early antihypertensive drug therapy with atenolol versus other therapies on pregnancy outcome, we reviewed the records of 398 women referred to our antenatal hypertension clinic between 1980 and 1995." | 3.69 | Effect of atenolol on birth weight. ( Beevers, DG; Beevers, M; Churchill, D; Lip, GY; Shaffer, LM, 1997) |
| "Adenosine is effective in rapidly terminating maternal narrow complex tachyarrhythmias before and during delivery in women with Wolff-Parkinson-White syndrome." | 3.68 | Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome. ( Afridi, I; Moise, KJ; Rokey, R, 1992) |
| "Forty term patients with pregnancy-induced hypertension were treated with the beta 1-adrenoceptor blocker atenolol (Tenormin R; ICI) for at least 7 days prior to parturition." | 3.67 | Influence of the beta 1-adrenoceptor blocker atenolol on antenatal cardiotocography. ( Montan, S; Sjöberg, NO; Solum, T, 1984) |
| "The transfer of atenolol and metoprolol to human breast milk was studied in 7 lactating women with hypertension." | 3.67 | Atenolol and metoprolol. A comparison of their excretion into human breast milk. ( Kulas, J; Lunell, NO; Rane, A; Rosing, U; Stéen, B, 1984) |
| "Slow-release nifedipine has been used in the treatment of severe hypertension in 23 pregnant women." | 3.67 | Nifedipine as a second line antihypertensive drug in pregnancy. ( Beevers, DG; Constantine, G; Luesley, DM; Reynolds, AL, 1987) |
| "Fetal circulation was studied by means of combined real-time and pulsed Doppler ultrasound in 14 women with pregnancy-associated hypertension before and during the first and third days of treatment with the beta 1-selective blocker, atenolol; in seven of the women the maternal uterine arcuate blood velocity waveform was also studied." | 3.67 | Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy. ( Liedholm, H; Lingman, G; Marsál, K; Montan, S; Sjöberg, NO; Solum, T, 1987) |
| "1 The pharmacological properties of atenolol suggest its possible usefulness in pregnancy-induced hypertension." | 3.66 | Atenolol in the treatment of pregnancy-induced hypertension. ( Cruickshank, JM; McAinsh, J; Thorley, KJ, 1981) |
| "Atenolol has been studied prospectively in the management of ten patients with essential hypertension during pregnancy." | 3.66 | Atenolol in the treatment of essential hypertension during pregnancy. ( Butters, L; Low, RA; Reid, JL; Rubin, PC, 1982) |
| "This study reports the results that were obtained in 56 cases of arterial hypertension in pregnancy solely by beta-blocking with Atenolol or Labetalol." | 3.66 | [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol]. ( Beauséjour, B; Blazquez, G; Faurie, C; Flouvat, B; Gérard, J; Lardoux, H; Rousset, D, 1983) |
| "Myocardial infarction is rare in pregnancy." | 2.39 | Myocardial infarction in a parturient. A case report with emphasis on medication and management. ( Haring, P; Hietakorpi, S; Koski, E; Nuutinen, LS; Purhonen, S; Söderlin, MK, 1994) |
| "Hyperdynamic patients had less preeclampsia, less severe preeclampsia, fewer deliveries <34 weeks, and fewer neonatal intensive care unit days compared with those requiring a vasodilator." | 1.35 | Outcomes of pregnancies at risk for hypertensive complications managed using impedance cardiography. ( Chaffin, DG; Webb, DG, 2009) |
| "Levobupivacaine was substituted for routine racemic bupivacaine to decrease the risk of drug-induced cardiotoxicity." | 1.33 | Long QT syndrome: anaesthetic management at delivery. ( Behl, S; Wauchob, TD, 2005) |
| "Her pregnancy was complicated by uncontrolled hypertension, which was not associated with other markers of disease activity." | 1.32 | Successful pregnancy in a patient with Takayasus arteritis. ( Al-Ghamdi, AA, 2003) |
| " The average daily dosage was 144." | 1.27 | Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol. ( Blazquez, G; Chouty, F; Flouvat, B; Gerard, J; Lardoux, H, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (48.98) | 18.7374 |
| 1990's | 12 (24.49) | 18.2507 |
| 2000's | 9 (18.37) | 29.6817 |
| 2010's | 3 (6.12) | 24.3611 |
| 2020's | 1 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Bellos, I | 1 |
| Pergialiotis, V | 1 |
| Papapanagiotou, A | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Bateman, BT | 1 |
| Patorno, E | 1 |
| Desai, RJ | 1 |
| Seely, EW | 1 |
| Mogun, H | 1 |
| Maeda, A | 1 |
| Fischer, MA | 1 |
| Hernandez-Diaz, S | 1 |
| Huybrechts, KF | 1 |
| Chaffin, DG | 1 |
| Webb, DG | 1 |
| Goya, M | 1 |
| Alvarez, M | 1 |
| Teixido-Tura, G | 1 |
| Merced, C | 1 |
| Pineda, V | 1 |
| Evangelista, A | 1 |
| Bayliss, H | 1 |
| Churchill, D | 2 |
| Beevers, M | 3 |
| Beevers, DG | 4 |
| Al-Ghamdi, AA | 1 |
| Darcie, S | 1 |
| Leone, CR | 1 |
| Calil, VM | 1 |
| Prescinotti, EP | 1 |
| Kahhale, S | 1 |
| Zugaib, M | 1 |
| Behl, S | 1 |
| Wauchob, TD | 1 |
| Zwiers, WJ | 1 |
| Blodgett, TM | 1 |
| Vallejo, MC | 1 |
| Finegold, H | 1 |
| Elias, GP | 1 |
| Sassaki, KT | 1 |
| Delbem, AC | 1 |
| Antoniali, C | 1 |
| Dubois, D | 1 |
| Petitcolas, J | 1 |
| Temperville, B | 1 |
| Klepper, A | 1 |
| Catherine, P | 1 |
| Rubin, PC | 6 |
| Butters, L | 5 |
| Clark, DM | 1 |
| Reynolds, B | 2 |
| Sumner, DJ | 1 |
| Steedman, D | 1 |
| Low, RA | 3 |
| Reid, JL | 3 |
| Smith, AM | 1 |
| Walker, H | 1 |
| Bonduelle, M | 1 |
| Greer, I | 1 |
| Calder, AA | 1 |
| Lardoux, H | 3 |
| Gerard, J | 3 |
| Blazquez, G | 3 |
| Flouvat, B | 3 |
| Ingemarsson, I | 2 |
| Liedholm, H | 2 |
| Montan, S | 5 |
| Westgren, M | 1 |
| Melander, A | 1 |
| Clark, D | 1 |
| Sumner, D | 1 |
| Belfield, A | 1 |
| Pledger, D | 1 |
| Evans, J | 1 |
| Adams, T | 1 |
| Kulas, J | 1 |
| Lunell, NO | 1 |
| Rosing, U | 1 |
| Stéen, B | 1 |
| Rane, A | 1 |
| Solum, T | 2 |
| Sjöberg, NO | 4 |
| Chouty, F | 1 |
| Beauséjour, B | 1 |
| Faurie, C | 1 |
| Rousset, D | 1 |
| Fowler, MB | 1 |
| Brudenell, M | 1 |
| Jackson, G | 1 |
| Holt, DW | 1 |
| Woods, DL | 1 |
| Morrell, DF | 1 |
| Thorley, KJ | 2 |
| McAinsh, J | 1 |
| Cruickshank, JM | 1 |
| Söderlin, MK | 1 |
| Purhonen, S | 1 |
| Haring, P | 1 |
| Hietakorpi, S | 1 |
| Koski, E | 1 |
| Nuutinen, LS | 1 |
| Shalev, Y | 1 |
| Ben-Hur, H | 1 |
| Hagay, Z | 1 |
| Blickstein, I | 1 |
| Epstein, M | 1 |
| Ayzenberg, O | 1 |
| Gelven, A | 1 |
| Caspi, A | 1 |
| Pearce, SH | 1 |
| Rees, CJ | 1 |
| Smith, RH | 1 |
| Räsänen, J | 1 |
| Jouppila, P | 1 |
| Lip, GY | 2 |
| Shaffer, LM | 1 |
| Lydakis, C | 1 |
| Shekhtman, MM | 1 |
| Elokhina, TB | 1 |
| Petrova, SB | 1 |
| Sokolova, MIu | 1 |
| Easterling, TR | 2 |
| Carr, DB | 1 |
| Brateng, D | 1 |
| Diederichs, C | 1 |
| Schmucker, B | 1 |
| Afridi, I | 1 |
| Moise, KJ | 1 |
| Rokey, R | 1 |
| Marsál, K | 2 |
| Fabregues, G | 1 |
| Alvarez, L | 1 |
| Varas Juri, P | 1 |
| Drisaldi, S | 1 |
| Cerrato, C | 1 |
| Moschettoni, C | 1 |
| Pituelo, D | 1 |
| Baglivo, HP | 1 |
| Esper, RJ | 1 |
| Blake, S | 1 |
| MacDonald, D | 1 |
| Kennedy, S | 1 |
| Cruickshank, DJ | 1 |
| Campbell, DM | 1 |
| Kawecka-Jaszcz, K | 1 |
| Skoczeń, M | 1 |
| Benedetti, TJ | 1 |
| Schmucker, BC | 1 |
| Carlson, KL | 1 |
| Constantine, G | 1 |
| Reynolds, AL | 1 |
| Luesley, DM | 1 |
| Olofsson, P | 1 |
| Sartor, G | 1 |
| Lingman, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maternal Hemodynamic Monitoring in Women Undergoing Cesarean Section by Use of NICaS Cardiac Impedance[NCT02902068] | 200 participants (Actual) | Observational | 2016-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for atenolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease | 2020 |
Myocardial infarction in a parturient. A case report with emphasis on medication and management.
Topics: Adult; Aspirin; Atenolol; Delivery, Obstetric; Drug Therapy, Combination; Female; Humans; Myocardial | 1994 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Ox | 1985 |
15 trials available for atenolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Glycemia in newborns of hypertensive mothers according to maternal treatment.
Topics: Antihypertensive Agents; Apgar Score; Atenolol; Blood Glucose; Epidemiologic Methods; Female; Fetal | 2004 |
Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension.
Topics: Adult; Atenolol; Bed Rest; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Hu | 1983 |
Antihypertensive therapy in pregnancy.
Topics: Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Labetalol; Ma | 1983 |
Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol.
Topics: Atenolol; Clinical Trials as Topic; Delivery, Obstetric; Double-Blind Method; Female; Fetal Heart; F | 1984 |
First year of life after the use of atenolol in pregnancy associated hypertension.
Topics: Atenolol; Body Height; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; H | 1984 |
Atenolol: side effects in the newborn infant.
Topics: Atenolol; Female; Humans; Hypertension; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnan | 1982 |
Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Female; Fetal Heart; Hemodyna | 1995 |
Atenolol and fetal growth in pregnancies complicated by hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Embryonic and Fetal Development; Female; Humans; Hypertens | 1999 |
[Atenolol use in gestosis: clinical and hemodynamic aspects].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Female; Gestational Age; Hemodynamics; Humans; Hyperte | 2000 |
Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Fetus; Heart Rate; Hemodynamics; Humans; Hype | 1992 |
Effectiveness of atenolol in the treatment of hypertension during pregnancy.
Topics: Adult; Atenolol; Female; Humans; Hypertension; Parity; Pregnancy; Pregnancy Complications, Cardiovas | 1992 |
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
Topics: Adult; Atenolol; Bendroflumethiazide; Birth Weight; Drug Therapy, Combination; Embryonic and Fetal D | 1991 |
Atenolol in essential hypertension during pregnancy.
Topics: Atenolol; Birth Weight; Blood Pressure; Double-Blind Method; Female; Fetal Growth Retardation; Gesta | 1990 |
Atenolol in essential hypertension during pregnancy.
Topics: Atenolol; Female; Fetal Growth Retardation; Humans; Hypertension; Labetalol; Pregnancy; Pregnancy Co | 1990 |
Effects of beta 1-adrenoceptor blockade in the treatment of hypertension during pregnancy in diabetic women.
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertensi | 1986 |
31 other studies available for atenolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.
Topics: Adrenergic beta-Antagonists; Atenolol; Bradycardia; Cohort Studies; Female; Humans; Hypertension; Hy | 2016 |
Outcomes of pregnancies at risk for hypertensive complications managed using impedance cardiography.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiography, Impedance; Female; Hemodynamics; Humans; Inf | 2009 |
Abdominal aortic dilatation during pregnancy in Marfan syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Atenolol; Ce | 2012 |
Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester?
Topics: Antihypertensive Agents; Atenolol; Embryonic and Fetal Development; Female; Humans; Hypertension; In | 2002 |
Successful pregnancy in a patient with Takayasus arteritis.
Topics: Adult; Antihypertensive Agents; Atenolol; Cesarean Section; Female; Humans; Pregnancy; Pregnancy Com | 2003 |
Long QT syndrome: anaesthetic management at delivery.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Anesthetics, Local; Anti-Arr | 2005 |
Successful vaginal delivery for a parturient with complete aortic coarctation.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anesthetics, Intravenous; Anesthetics, Local; Ao | 2006 |
Atenolol reduces salivary activity in pups of spontaneously hypertensive and normotensive rats treated during pregnancy and lactation.
Topics: Adrenergic beta-Antagonists; Amylases; Animals; Atenolol; Female; Hypertension; Lactation; Male; Org | 2008 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; | 1982 |
Beta-blockers for pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Labetalol; Pregnancy; Pregnancy | 1983 |
Which beta-blocker in pregnancy-induced hypertension?
Topics: Atenolol; Birth Weight; Ethanolamines; Female; Humans; Hypertension; Infant, Newborn; Labetalol; Pre | 1983 |
Fetal heart rate during treatment of maternal hypertension with beta-adrenergic antagonists. A preliminary report.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Fetal Heart; Heart Rate; Humans; Hypertension; Pindol | 1984 |
Beta blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Kinetics; Methyldopa; Oxprenolo | 1984 |
Atenolol and metoprolol. A comparison of their excretion into human breast milk.
Topics: Atenolol; Female; Fetal Blood; Humans; Hypertension; Metoprolol; Milk, Human; Pregnancy; Pregnancy C | 1984 |
Influence of the beta 1-adrenoceptor blocker atenolol on antenatal cardiotocography.
Topics: Apgar Score; Atenolol; Birth Weight; Female; Fetal Heart; Fetal Monitoring; Heart Rate; Humans; Hype | 1984 |
Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
Topics: Adolescent; Adult; Atenolol; Ethanolamines; Female; Fetus; Humans; Hypertension; Infant, Newborn; La | 1983 |
[Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
Topics: Adolescent; Adult; Atenolol; Delivery, Obstetric; Ethanolamines; Female; Fetal Heart; Fetal Monitori | 1983 |
Essential hypertension and pregnancy: successful outcome with atenolol.
Topics: Adult; Atenolol; Female; Fetal Blood; Humans; Hypertension; Maternal-Fetal Exchange; Pregnancy; Preg | 1984 |
Atenolol: side effects in a newborn infant.
Topics: Atenolol; Bradycardia; Female; Humans; Hypertension; Hypotension; Infant, Newborn; Male; Maternal-Fe | 1982 |
Atenolol: side effects in a newborn infant.
Topics: Atenolol; Female; Humans; Hypertension; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal E | 1982 |
Atenolol in the treatment of essential hypertension during pregnancy.
Topics: Atenolol; Blood Pressure; Female; Fetus; Heart Rate; Humans; Hypertension; Infant, Newborn; Pregnanc | 1982 |
Atenolol in the treatment of pregnancy-induced hypertension.
Topics: Adult; Atenolol; Female; Fetus; Humans; Hypertension; Kinetics; Pregnancy; Pregnancy Complications, | 1981 |
Successful delivery following myocardial ischemia during the second trimester of pregnancy.
Topics: Acute Disease; Adult; Atenolol; Cardiac Catheterization; Coronary Angiography; Female; Heparin; Huma | 1993 |
Fetal monitoring during maternal antiarrhythmic therapy.
Topics: Adenosine; Adult; Atenolol; Cardiotocography; Drug Therapy, Combination; Female; Humans; Infant, New | 1993 |
Effect of atenolol on birth weight.
Topics: Analysis of Variance; Anthropometry; Antihypertensive Agents; Atenolol; Birth Weight; Female; Fetal | 1997 |
Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiac Output; Embryonic and Fetal Development; Female; G | 2001 |
Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome.
Topics: Adenosine; Adult; Atenolol; Electrocardiography; Female; Heart Rate, Fetal; Humans; Obstetric Labor | 1992 |
Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring.
Topics: Atenolol; Cardiac Output; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Pregnancy; Pregna | 1989 |
Nifedipine as a second line antihypertensive drug in pregnancy.
Topics: Adult; Atenolol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypertensio | 1987 |
Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy.
Topics: Adult; Atenolol; Blood Flow Velocity; Blood Pressure; Female; Fetal Blood; Heart Rate; Heart Rate, F | 1987 |